Aptevo Therapeutics Inc. (APVO)
Market Closed
16 Jun, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
4. 54
-0.16
-3.4043%
After Hours
$
+0.05 +1.1013% 4. 59
10.45M Market Cap
- P/E Ratio
- Div Yield
13,471 Volume
-1.71 Eps
$ 4.7
Previous Close Want to track APVO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Aptevo Therapeutics Inc. (APVO) Statistics
Valuation metrics
Market Cap 10.45M
Enterprise value 350.18K
Trailing P/E (ttm) -0.19
Forward P/E -
PEG ratio -0
Price/Sales (ttm) -
Price/Book (mrq) 0.44
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.01
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 32.44K
Average volume (90 days) 37.9K
Price summary
52-Week low 3.8
52-Week high 235.98
Beta -
50-Day moving average 4.9
200-Day moving average 8.42
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:18
Last split Date 30 Dec 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -1.32%
Return on equity -1.98%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -24.75
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 13.69
Total debt (mrq) -
Total Debt/Equity (mrq) 0.38
Current ratio (mrq) 3.36%
Book value per share (mrq) 10.95
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
